1) Johnson SC, Chung RC, Deal CD, Boslego JW, Sadoff JC, Wood SW, Brinton CC, Tramont EC. Human Immunization with Pgh 3-2 Gonococcal Pilus Results in Cross-Reactive Antibody to the Cyanogen Bromide Fragment-2 of Pilin. J Infect Dis 1991;163:128-134.
2) Redfield RR, Birx DL, Ketter N, Tramont EC, Polonis V, Davis C, Brundage JF, Smith G, Johnson SC, et al. Human Immunodeficiency Virus (HIV) Vaccine Therapy: Phase 1 Safety and Immunogenicity. Evaluation of Post Infection Immune Modification by Active Immunization with Recombinant GP160. N Engl J Med 1991;324:1677-1684.
3) Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, Bolan G, Johnson SC, French P, Steen E, Radolf JD, Larsen S, for the Syphilis & HIV Study Group. A Randomized Trial of Enhanced Therapy for Early Syphilis in HIV-Infected and Uninfected Persons. N Eng J Med 1997;337:307-313.
4) Johnson S, Benson C, Johnson D, Weinberg A. Recurrent Cytomegalovirus (CMV) Retinitis in a Patient with HIV Infection Despite Potent Antiretroviral Therapy and Apparent Immune Reconstitution. Clinical Infectious Diseases 2001;32;815.
5) Johnson SC, Kuritzkes DR. Lopinavir. In AIDS Therapy (Editors: R Dolin, H Masur, M. Saag), 3rd Edition, Churchill Livingstone, New York, in press, 2007.